The Blatt-Kupperman menopausal index: A critique

Maturitas

Volumn 29, Issue 1, 1998, Pages 19-24

  Alder, Elizabeth ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Blatt Kupperman index; Measurement; Menopause; Psychometrics

Indexed keywords

FEMALE; HUMAN; MEASUREMENT; MENOPAUSE; PSYCHOMETRY; REVIEW; SCORING SYSTEM; SEXUALITY; SOCIAL ASPECT; SYMPTOM;

EID: 0032550757     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(98)00024-3     Document Type: Article

References (36)

1. Delaplaine R.W., Bottomy J.R., Blatt M., Weisbader H., Kupperman H.S. Effective control of the surgical menopause by estradiol pellet at the time of surgery Surgery. Gynecol Obstet. 94:1952;323-333.
2. Blatt M.H., Weisbader H., Kupperman H.S. Vitamin E and climacteric syndrome. Arch Intern Med. 91:1953;792-799.
3. Kupperman H.S., Wetchler B.B., Blatt M.H. Contemporary therapy of the menopausal syndrome. J Am Med Assoc. 171:1959;1627-1637.
4. Ballinger C.B. Psychiatric aspects of the menopause. Br J Psychol. 156:1990;773-787.
5. Bungay G.T., Vessey M.P., McPherson C.K. Survey of symptoms in middle life with special reference to the menopause. Br Med J. 2:1980;181-183.
6. Cittadini J., Ben J., Badano A.R.et al. The use of a new steroid (Org OD 14) in the climacteric syndrome. Reproduction. 6:1982;69-79.
7. Crona N., Samisoe G., Lindberg U.-B., Silverstolpe G. Treatment of climacteric complaints with ORG OD 14: A comparative study with oestradiol valerate and placebo. Maturitas. 9:1988;303-308.
8. Ross L.A., Alder E.M. Tibolone and climacteric symptoms. Maturitas. 21:1995;127-136.
9. Marslew Y., Riis B., Christiansen C. Progestogens: therapeutic and adverse effects in early postmenopausal women. Maturitas. 13:1991;7-16.
10. Jensen J., Christiansen C. Dose-response and withdrawal effects on climacteric symptoms after hormonal replacement therapy: A placebo-controlled therapeutic trial. Maturitas. 5:1983;125-133.
11. Wiklund I., Karlberg J., Mattson L.-A. Quality of life of post-menopausal women on a regimen of transdermal estradiol therapy: a double blind placebo controlled study. Am J Obstet Gynecol. 3:1993;824-830.
12. Van der Mooren MJ, Haneslaar AGJM, Schiff CPT, et al. Sequential three monthly versus monthly HRT: a prospective double blind randomised study. 8th Int Cong Menopause, Sydney, 1996 [Abstract F016].
13. Nedstrand EE, Wijma K, Lindgren MB, Hammar ML. Post menopausal women without vasomotor symptoms have better stress-coping than women with symptoms. 8th Int Cong Menopause, Sydney, 1996 [Abstract F109].
14. Wender MCO, Freitas FM, Castro JAS, et al. Effectiveness of tibolone×placebo in post menopausal women. 8th Int Cong Menopause, Sydney, 1996 [Abstract F136].
15. Crosigani PG, de Aloysio D, Pisati R, Huls GE. Efficacy and tolerability of a new oestradiol matrix patch (Estraderm MX®50) in the treatment of moderate to severe hot flushes. 8th Int Cong Menopause, Sydney, 1996 [Abstract F153].
16. Snijders MPML, Trootswijk AL, The HS, et al. Efficacy and tolerability benefits of matrix patches (Estraderm MX®50 and 100) in the treatment of moderate to severe post menopausal symptoms. 8th Int Cong Menopause, Sydney, 1996 [Abstract F154].
17. Chevalier O, Keil D, Huls GE, Monza GC. Efficacy and tolerability of a new oestradiol matrix patch (Estraderm MX®25) in the treatment of mild to moderate hot flushes. 8th Int Cong Menopause, Sydney, 1996 [Abstract F155].
18. Sorensen MB, Hansen TF, Ottesen B. Relationship between climacteric symptoms and impaired coronary blood flow, estimated by ECG-triggered magnetic resonance phase mapping. 8th Int Cong Menopause, Sydney, 1996 [Abstract F213].
19. Szlachic MJ. The effect of klimonorm on liver function and the menopausal syndrome. 8th Int Cong Menopause, Sydney, 1996 [Abstract P071].
20. Ciszek V, Poreba R. The estimation of Kupperman's index by applying estracomb TTS preparation. 8th Int Cong. Menopause, Sydney, 1996 [Abstract P271].
21. Marengo M, Rodriguez D, Vidal D, Gil Deza E. Hormonal replacement therapy (HRT) evaluation of a novel 25 days regimen with percutaneous estradiol (PE2) and micronized oral progesterone (MP). 8th Int Cong Menopause, Sydney, 1996 [Abstract P299].
22. Georgiev DB, Lordanova E, Phytooestrogens the alternative approach. 8th Int Cong Menopause, Sydney, 1996 [Abstract P309].
23. Golombok S, Rust J. Modern Psychometrics. The Science of Psychological Assessment. London: Routledge, 1989.
24. Pennebaker JW. The Psychology of Physical Symptoms New York: Springer-Verlag, 1982.
25. Holte A., Mikkelsen A. Psycho social determinants of climacteric complaints. Maturitas. 13:1991;205-215.
26. Hunter M. Emotional wellbeing, sexual behaviour and hormone replacement therapy. Maturitas. 12:1990;159-319.
27. Alder E.M., Bancroft J. The relationship between breast feeding persistence, sexuality and mood in postpartum women. Psychol Med. 18:1988;389-396.
28. Flesch R. A new readability yardstick. J Appl Psychol. 32:1948;221.
29. Greene JG. The Social and Psychological Origins of the Climacteric Syndrome. Gower: Aldershot, 1984.
30. Hunter M., Battersby R., Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas. 8:1986;217-228.
31. Holte A., Mikkelsen A. The menopausal syndrome: a factor analytic replication. Maturitas. 13:1991;193-203.
32. Perz J.M. Development of the Menopause Symptom Checklist. A factor analytic study of menopause associated symptoms. Women and Health. 25:1997;53-69.
33. Greene JG. Guide to the Greene Climacteric Scale. Glasgow: University of Glasgow, 1991.
34. Hunter M. The Women's Health Questionnaire: a measure of mid aged women's perceptions of their emotional and physical health. Psychol Health. 7:1992;45-54.
35. Nevinny-Stickel J. Double blind crossover study with Org OD 14 and placebo in post menopausal patients. Arch Gynecol. 234:1983;27-31.
36. Furuhjelm M., Karlgreen E., Carlstrom K. The effect of estrogen therapy on somatic and physical symptoms in post menopausal women. Acta Obstet Gynecol Scand. 63:1984;655-661.